Report - Acute Myeloid Leukemiaweb.brrh.com/msl/GrandRounds/2018/GrandRounds... · Enasidenib – Approved 8/2017, for the treatment of adult patients with relapsed or refractory AML with

Please pass captcha verification before submit form